Thorac Cardiovasc Surg 2008; 56(7): 398-400
DOI: 10.1055/s-2008-1038722
Original Cardiovascular

© Georg Thieme Verlag KG Stuttgart · New York

A Staged Approach towards Interventional Aortic Valve Implantation with a Sutureless Valve: Initial Human Implants

M. Shrestha1 , N. Khaladj1 , C. Bara1 , K. Hoeffler1 , C. Hagl1 , A. Haverich1
  • 1Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany
Further Information

Publication History

received Dec. 20, 2007

Publication Date:
22 September 2008 (online)

Abstract

Objective: Percutaneous implantable aortic valves may become an alternative to conventional approaches. The purpose of this study was to assess a new sutureless aortic valve (Perceval Sorin). As a first step, an open approach using cardiopulmonary bypass (CPB) was chosen to evaluate the feasibility of implantation. Methods: Between April and September 2007, 16 high-risk patients (13 females, aged 81 [76 – 88]) were operated on via a median sternotomy, using CPB and cardioplegia (Euro Score 17 [8 – 73]). All patients had significant aortic valve disease and seven of these patients had concomitant coronary artery disease. This pilot project was initiated with prior approval of the Institutional Review Board. All patients gave informed consent. Results: One patient died during hospital stay for unknown reasons. Autopsy revealed no valve related pathologies. CPB time was 60 min (41 – 130), cross-clamping time was 36 (22 – 79) min. Intraoperative as well as postoperative echocardiography revealed neither aortic insufficiency nor paravalvular leakage in any of the patients. Conclusions: The new approach as described here is a technically simple alternative to conventional aortic valve replacement in high-risk patients and offers the potential of less invasive approaches. It appears especially useful in patients with severe calcification of the aortic root. CPB and cross-clamping times were markedly reduced compared with patients who underwent conventional operations.

References

  • 1 Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F LMB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis.  Circulation. 2002;  106 3006-3008
  • 2 Lichtenstein S V, Cheung A, Ye J, Thompson C R, Carere R G, Pasupati S, Webb J G. Trans-apical transcatheter aortic valve implantation in humans: initial clinical experience.  Circulation. 2006;  114 591-596
  • 3 Webb J B, Chandavimol M, Thompson C R. et al . Percutaneous aortic valve implantation retrograde from the femoral artery.  Circulation. 2006;  113 842-850
  • 4 Grube E, Laborde J C, Zickmann B. et al . First report on a human percutaneous transluminal implantation of a self expanding valve prosthesis for interventional treatment of aortic valve stenosis.  Cathet Cardiovasc Interv. 2005;  66 465-469
  • 5 Hanzel G S, Harrity P, Screiber T L. et al . Retrograde percutaneous aortic valve implantation for critical aortic stenosis.  Cathet Cardiovasc Interv. 2005;  64 322-326
  • 6 Walther T, Simon P, Dewey T, Wimmer-Greinecker G, Falk V, Kasimir M T, Doss M, Borger M A, Schuler G, Glogar D, Fehske W, Wolner E, Mohr F W, Mack M. Transapical minimally invasive aortic valve implantation: multicenter experience.  Circulation. 2007;  116 (11 Suppl) I240-I245
  • 7 Walther T, Falk V, Borger M A, Dewey T, Wimmer-Greinecker G, Schuler G, Mack M, Mohr F W. Minimally invasive transapical beating heart aortic valve implantation – proof of concept.  Eur J Cardiothorac Surg. 2007;  31 9-15
  • 8 Huber C H, von Segesser L. Direct access valve replacement (DAYR) – are we entering a new era in cardiac surgery?.  Eur J Cardiothorac Surg. 2006;  29 380-385
  • 9 Vassiliades T A, Block P C, Cohn L H, Adams D H, Borer J S, Feldman T, Holmes D R, Laskey W K, Lyte B W, Mack M J, Williams D O. The clinical development of percutaneous heart valve technology. A position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI).  J Am Coll Cardiol. 2005;  45 1554-1560
  • 10 Babaliaros V, Block P. State of the art percutaneous intervention for the treatment of valvular heart disease: a review of the current technologies and ongoing research in the field of percutaneous valve replacement and repair.  Cardiology. 2007;  107 87-96
  • 11 Lichtenstein S V, Cheung A, Ye J, Thompson C R, Carere R G, Pasupati S, Webb J G. Transapical transcatheter aortic valve implantation in humans: initial clinical experience.  Circulation. 2006;  114 591-596
  • 12 Wendt D, Thielmann M, Buck T, Jánosi R A, Bossert T, Pizanis N, Kamler M, Jakob H. First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis.  Eur J Cardiothorac Surg. 2008;  33 542-547

Dr. MBBS Malakh Shrestha

Hannover Medical School
Department of Thoracic and Cardiovascular Surgery

Carl-Neuberg-Str. 1

30625 Hannover

Germany

Phone: + 49 51 15 32 21 57

Fax: + 49 51 15 32 54 04

Email: Shrestha.malakh.Lal@mh-hannover.de

    >